Bihag, Joseph T.
HRN: 22 55 00 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/26/2023
CEFTAZIDIME 1GM (VIAL)
01/26/2023
02/01/2023
IV
1gm
Q8
TB Bronchiectasis; CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes